HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Gaetano Caramori Selected Research

Gaetano Caramori Research Topics

Disease

17	Asthma (Bronchial Asthma) 09/2009 - 06/2002
13	Chronic Obstructive Pulmonary Disease (COPD) 09/2009 - 01/2003
12	Inflammation 06/2009 - 09/2002
3	Infection 10/2008 - 01/2006
3	Airway Remodeling 02/2008 - 01/2004
2	Cystic Fibrosis (Mucoviscidosis) 03/2006 - 05/2005
1	Pulmonary Emphysema 10/2006
1	Bacterial Infections (Bacterial Infection) 05/2006
1	Pneumonia (Pneumonitis) 05/2005
1	Cough 01/2005
1	Necrosis 01/2005
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2004
1	Leukemia 01/2004

Drug/Important Bio-Agent (IBA)

5	GlucocorticoidsIBA 04/2009 - 01/2003
5	Transcription Factors (Transcription Factor)IBA 03/2009 - 08/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2009 - 06/2002
3	Messenger RNA (mRNA)IBA 03/2006 - 01/2005
2	SmokeIBA 04/2009 - 06/2006
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2009 - 06/2006
2	NF-kappa B (NF-kB)IBA 03/2009 - 03/2006
2	Xanthine OxidaseIBA 10/2008 - 11/2005
2	p38 Mitogen-Activated Protein KinasesIBA 09/2008 - 03/2006
2	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 02/2008 - 09/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2006 - 09/2002
2	Phosphotransferases (Kinase)IBA 03/2006 - 01/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2005 - 08/2004
2	CytokinesIBA 08/2005 - 08/2004
2	ChemokinesIBA 08/2005 - 08/2004
2	Proteins (Proteins, Gene)IBA 08/2005 - 08/2004
2	EnzymesIBA 08/2005 - 08/2004
2	SteroidsIBA 09/2004 - 08/2002
2	Theophylline (Theon)FDA LinkGeneric 01/2003 - 06/2002
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 09/2009
1	Oxypurinol (Oxipurinol)IBA 10/2008
1	Glutathione (Reduced Glutathione)IBA 10/2008
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2008
1	omalizumab (Xolair)FDA Link 09/2008
1	Oxidants (Oxidizing Agents)IBA 09/2008
1	anti-IgEIBA 09/2008
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2006
1	Peptide Hydrolases (Proteases)IBA 10/2006
1	Biological Markers (Surrogate Marker)IBA 10/2006
1	telithromycin (Ketek)FDA Link 07/2006
1	GasesIBA 05/2006
1	Inositol (Myoinositol)IBA 03/2006
1	1-Phosphatidylinositol 3-Kinase (PI 3 Kinase)IBA 03/2006
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2006
1	Reactive Nitrogen SpeciesIBA 11/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 11/2005
1	3-nitrotyrosineIBA 11/2005
1	Peroxidase (Myeloperoxidase)IBA 11/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2005
1	Interleukin-8 (Interleukin 8)IBA 05/2005
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 05/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005
1	I-kappa B KinaseIBA 11/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2004
1	imatinib (Gleevec)FDA Link 01/2004
1	Protein Kinases (Protein Kinase)IBA 01/2004
1	tiotropium (Spiriva)FDA Link 01/2003
1	Bronchodilator Agents (Bronchodilators)IBA 01/2003
1	CREB-Binding ProteinIBA 08/2002

Therapy/Procedure

2	Aftercare (After-Treatment) 02/2008 - 01/2003
1	Nebulizers and Vaporizers (Inhaler) 06/2009